logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10696624 B1

PDFFull Text
Date of Patent:
Jun. 30, 2020

Filed:

Jun. 17, 2016

Cannabinoid receptor cb2 ligand 4-(aminomethyl)-n,n-dialkylanilines

Applicant:

University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Xiang-Qun Xie, Sewickley, PA (US);

Abdulrahman Almehizia, Pittsburgh, PA (US);

Peng Yang, Pittsburgh, PA (US);

Assignee:

University of Pittsburgh—Of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Attorney:

Foley & Lardner LLP

Primary Examiner:

Nizal S Chandrakumar

Int. Cl.
CPC ...
C07C 311/29 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 333/34 (2006.01); C07D 333/38 (2006.01); C07C 311/13 (2006.01); C07C 311/18 (2006.01); C07D 401/12 (2006.01); C07D 241/44 (2006.01); A61P 19/10 (2006.01); A61P 35/00 (2006.01); C07D 213/42 (2006.01); C07D 317/58 (2006.01);
U.S. Cl.
CPC ...
C07C 311/29 (2013.01); A61P 19/10 (2018.01); A61P 35/00 (2018.01); C07C 311/13 (2013.01); C07C 311/18 (2013.01); C07D 213/42 (2013.01); C07D 241/44 (2013.01); C07D 317/58 (2013.01); C07D 333/34 (2013.01); C07D 333/38 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01);
Abstract

Disclosed herein are novel cannabionid receptor-2 (CB2) agonists and inverse agonists represented by Formula (I), and method of modulating the activity of CB2 by contacting the CB-2 receptor with a compound of Formula (I). Also, disclosed are methods for treating multiple myeloma or osteoporosis in a mammal in need thereof by modulating the activity of a cannabinoid receptor-2 (CB2).

Find Patent Forward Citations

Xie, Xiang-Qun. (2020). Cannabinoid receptor cb2 ligand 4-(aminomethyl)-n,n-dialkylanilines (U.S. Patent No. 10696624). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10696624

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…